Indocyanine Green for Revising Weight Loss Surgery

Indocyanine Green Fluorescence Angiography (ICG-FA) in Revisional Bariatric Surgery

Recruiting N/A Interventional Study
Obesity Bariatric Surgery
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Diagnostic
Participants needed
108 (estimated)
Sponsor
Instituto Mexicano del Seguro Social · Government
Who this trial is looking for

This trial is looking for people who are set to have weight loss surgery again. Participants will receive a special green fluorescent product during the surgery to help identify blood vessels.

Are You a Good Fit for This Trial?
Rules you out Liver disease

You may be able to join if

  • I have been diagnosed with obesity.
  • I have a BMI of 30 or higher.
  • I am scheduled for revisional bariatric surgery.

You may not be able to join if

  • I am allergic to iodides.
  • I use anticoagulants with sodium bisulfite.
  • I had radioactive iodine studies in the past 7 days.
  • I am pregnant, breastfeeding, or planning to become pregnant in the next year.
  • I have a history of liver disease.
  • My bilirubin level is above 1.5 times the normal limit.
  • My AST level is above the normal limit.
  • I have withdrawn my consent to participate.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
This study will compare different doses of a green fluorescent product that is administered during weight loss surgery in order to observe where blood vessels are located. There is uncertainty around the optimal dose of this product for patients with obesity, so this study will aim to study if the dose in the minimal range recommended by international guidelines is sufficient for most patients or …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Diagnosis of obesity with a BMI ≥ 30 kg/m² * Scheduled for revisional bariatric surgery Exclusion Criteria: * Allergy to iodides. * Anticoagulation with products containing sodium bisulfite (due to the risk of ICG-FA inactivation). * Use of radioactive iodine studies within …
Contacts

No contact information available.